<DOC>
	<DOCNO>NCT02940262</DOCNO>
	<brief_summary>This clinical trial study well 68Ga-PSMA-11 positron emission tomography ( PET ) /computed tomography ( CT ) work detect prostate cancer come back patient initial therapy . Diagnostic procedure , 68Ga-PSMA-11PET/CT , may help doctor detect tumor come back initial therapy .</brief_summary>
	<brief_title>68Ga-PSMA-11 PET/CT Detecting Recurrent Prostate Cancer Patients After Initial Therapy</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To evaluate 68gallium ( Ga ) -prostate-specific membrane antigen ( PSMA ) PET/CT detection recurrent prostate cancer initial therapy patient elevate PSA non-contributory bone scintigraphy , compute tomography ( CT ) magnetic resonance imaging ( MRI ) . OUTLINE : Patients receive gallium Ga 68-labeled PSMA ligand glutamic acid ( Glu ) -urea-lysine ( Lys ) ( Ahx ) intravenously ( IV ) 45-60 minute undergo PET/CT . After completion study , patient follow every 3-6 month 1 year .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Edetic Acid</mesh_term>
	<criteria>1 . Histopathological proven prostate adenocarcinoma . 2 . Rising PSA definitive therapy prostatectomy radiation therapy ( external beam brachytherapy ) . . Post radical prostatectomy ( RP ) AUA recommendation i. PSA great 0.2 ng/mL measure 6 week RP , ii . Confirmatory persistent PSA great 0.2 ng/mL b. Postradiation therapy ASTROPhoenix consensus definition i. Nadir + great equal 2 ng/mL rise PSA 3 . Able provide write consent . 4 . Karnofsky performance status 50 ( ECOG/WHO equivalent ) . 1 . Investigational therapy prostate cancer . 2 . Unable lie flat , still tolerate PET scan . 3 . Prior history malignancy within last 2 year , skin basal cell cutaneous superficial squamous cell carcinoma metastasize superficial bladder cancer . 4 . Contraindication furosemide administration include prior allergy adverse reaction furosemide sulfa drug . ( Note : This exclusion criterion remove Furosemide omit part PET image protocol secondgeneration scatter correction available use PET device ) .</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>